NCT04325555

Pre-exposure Prophylaxis: A Miracle Drug or a Moral Hazard

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 2,647 (actual)
• Sponsor: New York University · Academic / Other
• Sex: Male
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The investigators study the behavioral consequences of Pre-exposure Prophylaxis or PrEP on sexual health behaviors, sexual health outcomes, and partner selection preferences. The study collects observational, self-reported data on PrEP status, PrEP taking-history, PrEP adherence over the last 30 days, STD diagnosis history dating back to January 2015 up to December 2019, sexual health behaviors (e.g., positioning, number of lifetime/recent partners, condom adherence etc.), and various demographic characteristics. The survey finishes with a conjoint experiment which asks respondents to select between two potential partners, and follow-up question about each profiles. Potential partners' characteristics include recreational drug use and condom adherence. Recruitment is conducted via running an ad on Facebook in New York, London, Toronto and Sydney for comparative purposes, as these metro areas have varying levels of PrEP use and accessibility.

Detailed description

See statistical analysis plan.

Conditions

• Syphilis
• Chlamydia
• Gonorrhea
• Sexually Transmitted Diseases

Interventions

Type	Name	Description
DRUG	PrEP	The investigators measure self-reported PrEP status as exposure, i.e., PrEP status is not confirmed via matched medical records or any other type of information directly collected form subjects.

Timeline

• Start date: 2020-01-20
• Primary completion: 2020-03-15
• Completion: 2020-03-15
• First posted: 2020-03-27
• Last updated: 2020-10-14

Locations

1 site across 1 country: United Arab Emirates